124 related articles for article (PubMed ID: 38462034)
1. Myotubularin-related-protein-7 inhibits mutant (G12V) K-RAS by direct interaction.
Weidner P; Saar D; Söhn M; Schroeder T; Yu Y; Zöllner FG; Ponelies N; Zhou X; Zwicky A; Rohrbacher FN; Pattabiraman VR; Tanriver M; Bauer A; Ahmed H; Ametamey SM; Riffel P; Seger R; Bode JW; Wade RC; Ebert MPA; Kragelund BB; Burgermeister E
Cancer Lett; 2024 Apr; 588():216783. PubMed ID: 38462034
[TBL] [Abstract][Full Text] [Related]
2. Myotubularin related protein 7 is essential for the spermatogonial stem cell homeostasis via PI3K/AKT signaling.
Zhao D; Shen C; Gao T; Li H; Guo Y; Li F; Liu C; Liu Y; Chen X; Zhang X; Wu Y; Yu Y; Lin M; Yuan Y; Chen X; Huang X; Yang S; Yu J; Zhang J; Zheng B
Cell Cycle; 2019 Oct; 18(20):2800-2813. PubMed ID: 31478454
[TBL] [Abstract][Full Text] [Related]
3. Myotubularin-related protein 7 inhibits insulin signaling in colorectal cancer.
Weidner P; Söhn M; Gutting T; Friedrich T; Gaiser T; Magdeburg J; Kienle P; Ruh H; Hopf C; Behrens HM; Röcken C; Hanoch T; Seger R; Ebert MP; Burgermeister E
Oncotarget; 2016 Aug; 7(31):50490-50506. PubMed ID: 27409167
[TBL] [Abstract][Full Text] [Related]
4. Myotubularin-related protein 7 activates peroxisome proliferator-activated receptor-gamma.
Weidner P; Söhn M; Schroeder T; Helm L; Hauber V; Gutting T; Betge J; Röcken C; Rohrbacher FN; Pattabiraman VR; Bode JW; Seger R; Saar D; Nunes-Alves A; Wade RC; Ebert MPA; Burgermeister E
Oncogenesis; 2020 Jun; 9(6):59. PubMed ID: 32522977
[TBL] [Abstract][Full Text] [Related]
5. Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9.
Mochizuki Y; Majerus PW
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9768-73. PubMed ID: 12890864
[TBL] [Abstract][Full Text] [Related]
6. Silencing myotubularin related protein 7 enhances proliferation and early differentiation of C2C12 myoblast.
Yuan Z; Chen Y; Zhang X; Zhou X; Li M; Chen H; Wu M; Zhang Y; Mo D
Biochem Biophys Res Commun; 2017 Mar; 484(3):592-597. PubMed ID: 28153733
[TBL] [Abstract][Full Text] [Related]
7. Myotubularin regulates Akt-dependent survival signaling via phosphatidylinositol 3-phosphate.
Razidlo GL; Katafiasz D; Taylor GS
J Biol Chem; 2011 Jun; 286(22):20005-19. PubMed ID: 21478156
[TBL] [Abstract][Full Text] [Related]
8. Expression of the EGFR-RAS Inhibitory Proteins DOK1 and MTMR7 and its Significance in Colorectal Adenoma and Adenoma Recurrence.
Gutting T; Merkel A; Fink DJ; Hetjens S; Weidner P; Yu Y; Kähler G; Ebert MP; Gaiser T; Burgermeister E; Belle S
J Gastrointestin Liver Dis; 2021 Dec; 30(4):446-455. PubMed ID: 34941983
[TBL] [Abstract][Full Text] [Related]
9. Targeting ERK1/2 protein-serine/threonine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Apr; 142():151-168. PubMed ID: 30794926
[TBL] [Abstract][Full Text] [Related]
10. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase.
Besset V; Scott RP; Ibáñez CF
J Biol Chem; 2000 Dec; 275(50):39159-66. PubMed ID: 10995764
[TBL] [Abstract][Full Text] [Related]
11. ΔNp63α is a common inhibitory target in oncogenic PI3K/Ras/Her2-induced cell motility and tumor metastasis.
Hu L; Liang S; Chen H; Lv T; Wu J; Chen D; Wu M; Sun S; Zhang H; You H; Ji H; Zhang Y; Bergholz J; Xiao ZJ
Proc Natl Acad Sci U S A; 2017 May; 114(20):E3964-E3973. PubMed ID: 28468801
[TBL] [Abstract][Full Text] [Related]
12. K-Ras
Zhang J; Liu W; Dong H; Wang W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2048-2057. PubMed ID: 31126199
[No Abstract] [Full Text] [Related]
13. Elastin peptides activate extracellular signal-regulated kinase 1/2 via a Ras-independent mechanism requiring both p110gamma/Raf-1 and protein kinase A/B-Raf signaling in human skin fibroblasts.
Duca L; Lambert E; Debret R; Rothhut B; Blanchevoye C; Delacoux F; Hornebeck W; Martiny L; Debelle L
Mol Pharmacol; 2005 Apr; 67(4):1315-24. PubMed ID: 15653554
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 augments K-Ras activation and triggers a Ras signal that attenuates ERK but not phosphoinositide 3-kinase activity.
Elad-Sfadia G; Haklai R; Balan E; Kloog Y
J Biol Chem; 2004 Aug; 279(33):34922-30. PubMed ID: 15205467
[TBL] [Abstract][Full Text] [Related]
15. Pan-Raf co-operates with PI3K-dependent signalling and critically contributes to myeloma cell survival independently of mutated RAS.
Müller E; Bauer S; Stühmer T; Mottok A; Scholz CJ; Steinbrunn T; Brünnert D; Brandl A; Schraud H; Kreßmann S; Beilhack A; Rosenwald A; Bargou RC; Chatterjee M
Leukemia; 2017 Apr; 31(4):922-933. PubMed ID: 27686868
[TBL] [Abstract][Full Text] [Related]
16. Combined targeting of BRAF and CRAF or BRAF and PI3K effector pathways is required for efficacy in NRAS mutant tumors.
Jaiswal BS; Janakiraman V; Kljavin NM; Eastham-Anderson J; Cupp JE; Liang Y; Davis DP; Hoeflich KP; Seshagiri S
PLoS One; 2009 May; 4(5):e5717. PubMed ID: 19492075
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic resistance to the MEK1/2 inhibitor AZD6244 (ARRY-142886) is associated with weak ERK1/2 signalling and/or strong PI3K signalling in colorectal cancer cell lines.
Balmanno K; Chell SD; Gillings AS; Hayat S; Cook SJ
Int J Cancer; 2009 Nov; 125(10):2332-41. PubMed ID: 19637312
[TBL] [Abstract][Full Text] [Related]
18. Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
Kimple RJ; Vaseva AV; Cox AD; Baerman KM; Calvo BF; Tepper JE; Shields JM; Sartor CI
Clin Cancer Res; 2010 Feb; 16(3):912-23. PubMed ID: 20103665
[TBL] [Abstract][Full Text] [Related]
19. Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway.
Blondeau F; Laporte J; Bodin S; Superti-Furga G; Payrastre B; Mandel JL
Hum Mol Genet; 2000 Sep; 9(15):2223-9. PubMed ID: 11001925
[TBL] [Abstract][Full Text] [Related]
20. Receptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.
Ebi H; Corcoran RB; Singh A; Chen Z; Song Y; Lifshits E; Ryan DP; Meyerhardt JA; Benes C; Settleman J; Wong KK; Cantley LC; Engelman JA
J Clin Invest; 2011 Nov; 121(11):4311-21. PubMed ID: 21985784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
